Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeng-Xian Sun

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|January 24, 2024
Cost-effectiveness analysis of mecapegfilgrastim and recombinant human granulocyte stimulating factor for primary prophylaxis of chemotherapy-induced neutropenia in non-small cell lung cancerYong-Li Gu, Zeng-Xian Sun, Ying Sun, et al.
Frontiers in Pharmacology|September 13, 2023
Analysis of 12 cases of antineoplastic agents-induced interstitial lung diseaseXiao Li, Yong-Li Gu, Xu-Chao Liu, et al.
Frontiers in Pharmacology|September 30, 2022
A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary diseaseYong-Li Gu, Zeng-Xian Sun, Ying Sun, et al.
Journal of Clinical Pharmacy and Therapeutics|January 19, 2020
Comparative efficacies of nebulized budesonide and systemic corticosteroids in the treatment of exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysisYong-Li Gu, Jie Pang, Zeng-Xian Sun, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Clinical Pharmacology and Therapeutics|January 24, 2024
Cost-effectiveness analysis of mecapegfilgrastim and recombinant human granulocyte stimulating factor for primary prophylaxis of chemotherapy-induced neutropenia in non-small cell lung cancerYong-Li Gu, Zeng-Xian Sun, Ying Sun, et al.
Frontiers in Pharmacology|September 13, 2023
Analysis of 12 cases of antineoplastic agents-induced interstitial lung diseaseXiao Li, Yong-Li Gu, Xu-Chao Liu, et al.
Frontiers in Pharmacology|September 30, 2022
A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary diseaseYong-Li Gu, Zeng-Xian Sun, Ying Sun, et al.
Journal of Clinical Pharmacy and Therapeutics|January 19, 2020
Comparative efficacies of nebulized budesonide and systemic corticosteroids in the treatment of exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysisYong-Li Gu, Jie Pang, Zeng-Xian Sun, et al.
Pageof 1